HeraNano Therapeutics is a pre-seed biotechnology startup pioneering nanoparticle drug delivery systems for women’s health applications. Spun out of Dr. Rachel Riley’s research lab at Rowan University, HeraNano's mission is to develop safe, effective, and accessible therapies that address critical unmet needs in women’s health, with the potential to transform care and improve outcomes for women worldwide.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Camden, Nj, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Camden, NJ
- Competitors
- SIB2023 Congresso Nazionale Società Italiana Biomateriali - Camerino, Stark Biosciences, Sierra Biosystems Inc., American Association of Pharmaceutical Sciences - UMich Student Chapter, NanoBioLab, CONDUCTink, Pharmosaic Consulting, Gene Universal Inc., Translational Retinal Research Laboratory, Geneva Biotech.
Heranano Therapeutics Questions
Heranano Therapeutics's LinkedIn profile is https://www.linkedin.com/company/heranano-therapeutics
Heranano Therapeutics has
1 employees.
View email and phone details for 1
employees at Heranano Therapeutics.
Heranano Therapeutics's industry is
Biotechnology Research
Heranano Therapeutics's top competitors are
Sib2023 Congresso Nazionale Società Italiana Biomateriali - Camerino,
Stark Biosciences,
Sierra Biosystems Inc.,
American Association Of Pharmaceutical Sciences - Umich Student Chapter,
Nanobiolab,
Conductink,
Pharmosaic Consulting,
Gene Universal Inc.,
Translational Retinal Research Laboratory,
Geneva Biotech.
Heranano Therapeutics's categories are Biotechnology Research
Heranano Therapeutics's founding year is 2024
